Funding
Funding not disclosed
Founders
Product
Problem
Healthcare providers face challenges in identifying the root causes of complex health issues and developing effective, personalized treatment plans. Traditional diagnostic methods often lack the depth to uncover subtle metabolic and microbial imbalances, leading to delayed or suboptimal patient outcomes. Keeping pace with the rapid advancements in precision medicine and integrating new research into clinical practice is also a significant hurdle.
Solution
Theriome provides a comprehensive multi-omic and metabolic testing platform designed to equip healthcare professionals with advanced diagnostic capabilities. The platform analyzes a wide range of biological markers to identify key health domains and uncover underlying causes of patient conditions, moving beyond conventional diagnostics. By leveraging AI-driven protocols and continuously updated scientific literature, Theriome empowers clinicians to accelerate patient results and enhance preventative care strategies. This allows practitioners to offer more precise and effective treatment plans, improving patient health trajectories and differentiating their practice through cutting-edge diagnostics.
Target Audience
Theriome serves healthcare professionals, including physicians, functional medicine practitioners, and clinical researchers, who seek advanced diagnostic tools to personalize patient care and improve treatment efficacy.
Features
- **Multi-Omic Analysis:** Integrates data from genomics, transcriptomics, proteomics, metabolomics, and microbiomics for a holistic view of patient health.
- **Metabolic Profiling (Aristotle Test):** Measures 126 sentinel metabolites, significantly exceeding standard comprehensive metabolic panels, to provide detailed insights into metabolic health, including vitamins, neurotransmitters, and antioxidants.
- **Microbiome Analysis (Élie Test):** Utilizes shotgun metagenomic sequencing for strain-level resolution of the gut microbiome, offering comprehensive taxonomic profiling and metabolic pathway analysis.
- **AI-Driven Personalized Protocols:** Generates tailored treatment recommendations based on multi-omic data and extensive digital twin simulations to optimize patient health outcomes.
- **Health Domain Assessment:** Identifies and quantifies patient health across 12 key domains, including biological age, inflammation, mitochondrial function, and gut health.
- **Methylation Profile:** Assesses methylation status through key markers, providing insights into gene regulation and cellular function with a proprietary Methylation Efficiency Index.
- **Research Services:** Offers targeted metabolomics services utilizing high-resolution mass spectrometry for academic, biotech, and clinical trial research.
- **Sample Type Versatility:** Accepts a broad range of biological samples including blood (plasma, serum, whole blood, DBS), urine, feces, CSF, tissue biopsies, and cell culture media.